GO
Loading...

Health Care

More

  • Obesity's New Status as Disease May Hurt Insurers Thursday, 20 Jun 2013 | 12:44 PM ET

    The AMA's new recognition of obesity as a "disease" could put a dent into insurers' bottom lines—at least in the short-term—but boost profits for makers of weight-loss drugs.

  • Obesity Officially a Disease     Wednesday, 19 Jun 2013 | 1:42 PM ET

    The American Medical Association says obesity should be classified as a disease. CNBC's Bertha Coombs reports AMA's Patrice Harris says the hope is for doctors to be more proactive in treating obese patients.

  • Will Obamacare Hurt Jobs? It's Already Happening Wednesday, 19 Jun 2013 | 12:21 PM ET
    President Barack Obama speaks about the Affordable Care Act in San Jose, Calif.

    Small business owners are already curtailing hiring because of concerns over the cost of Obamacare, a recent survey found.

  • Cramer: 2 Ugly Ducklings to Become Beautiful Swans? Tuesday, 18 Jun 2013 | 6:17 PM ET

    With the Dow up more than 2000 points for the year, Jim Cramer thinks now is a good time to single out stocks that haven’t rallied, but soon could.

  • Health Care's New Normal: Low Cost Inflation Tuesday, 18 Jun 2013 | 12:03 AM ET

    Already sluggish health-care inflation is projected to slow down even more in 2014 as consumers, employers and the federal government continue looking to cut medical costs, a new report said Tuesday.

  • Obamacare Insurance Plans to Vary Sharply by State Monday, 17 Jun 2013 | 1:03 PM ET

    Months before Americans buy coverage under Obamacare, it's becoming clear that choices for millions of people will vary depending on where they live. The NYT reports.

  • High Court's Generic Drug Ruling 'a Holy Mess' Monday, 17 Jun 2013 | 3:58 PM ET
    Supreme Court Justice Stephen Breyer

    A Supreme Court decision gives the FTC the go-ahead to continue suing drug makers over deals that delay generic versions from being sold.

  • Court: 'Pay-to-Delay' Generic Drugs Can Be Illegal Monday, 17 Jun 2013 | 10:52 AM ET

    The Supreme Court says deals between pharmaceutical companies and their generic drug competitors can sometimes be illegal.

  • Cramer: This Break-Up Creating Immense Value Friday, 14 Jun 2013 | 6:15 PM ET

    Jim Cramer believes this company is about to create immense value with the stroke of a pen.

  • Nutrisystem CEO Targets Battle of the Bulge     Friday, 14 Jun 2013 | 8:16 AM ET

    Dawn Zier, President & CEO of Nutrisystem, discusses her company's plans to set up programs designed to meet the needs of people with special dietary needs, and its expansion into selling its products in Wal-Mart.

  • Genome Research Benefits Growing, Getting Cheaper Sunday, 16 Jun 2013 | 10:05 AM ET

    Biotech and drug companies say the benefits of genome research are on the way, and just as importantly, advances are pushing the technology toward affordability.

  • High Court's Ruling on DNA Could Boost Biotech Thursday, 13 Jun 2013 | 4:33 PM ET
    Justice Clarence Thomas

    A unanimous Supreme Court decision barred patents on naturally occurring DNA, but analysts said the ruling did little harm to biotech companies.

  • Lack of Dental Care Keeps Many Out of Work Wednesday, 12 Jun 2013 | 3:45 PM ET
    A patient is treated as part of a program in which some 600 doctors and support staff volunteer to treat people who have difficulty getting care.

    Like many of the 2,200-plus people who showed up for a 5:30 a.m. dental clinic last month, Patty Kennedy knows that bad teeth translate into poor employment prospects.

  • Why Cyclicals Are Hot for Investors This Summer Wednesday, 12 Jun 2013 | 5:19 AM ET

    Cyclicals are heating up as the summer approaches and the economy starts to show signs of improvement, analysts say.

  • GlaxoSmithKline Fires R&D Boss in Data Scandal Tuesday, 11 Jun 2013 | 6:35 PM ET
    A worker in vaccine production at drugmaker GlaxoSmithKline in Saint-Amand-les-Eaux, France.

    GlaxoSmithKline fired the head of its R&D operations in China after a tipster spurred an inquiry that found "misrepresented" data were used in a multiple sclerosis study.

  • Plan-B for All—No Age Limits on Morning-After Pill Tuesday, 11 Jun 2013 | 10:17 AM ET

    Obama administration to scrap age restrictions on the sale of morning-after pills, making the emergency contraception available to women and girls of any age without a prescription.

  • Universal Health CEO: Obamacare=Healthy Earnings Tuesday, 11 Jun 2013 | 3:17 PM ET
    Alan Miller, CEO, Universal Health Services

    Obamacare's implementation may look like a "train wreck," but Universal Health Services CEO Alan Miller says his $7 billion hospital company is well-positioned for the changes.

  • Susan Komen CEO Pay Draws Fire as Donations Drop Monday, 10 Jun 2013 | 12:45 PM ET
    Nancy Brinker, Founder, Susan G. Komen for the Cure.

    Months after the Komen Foundation's decision to cut Planned Parenthood funding sparked widespread backlash, the group's CEO still holds her position and received a large raise.

  • Experts Mull New Rules of Road for Kid Transplants Monday, 10 Jun 2013 | 11:36 AM ET

    Transplant experts will meet to decide whether and how to change the rules for children, after the parents of two youngsters successfully sued to get restrictions temporarily lifted.

  • AstraZeneca Buys Pearl for Up to $1.15 Billion Monday, 10 Jun 2013 | 5:37 AM ET
    Respiratory therapists assess, treat, and care for patients with breathing disorders.

    AstraZeneca is to buy U.S. respiratory drug specialist Pearl Therapeutics for up to $1.15 billion, as Britain's second biggest drugmaker steps up a drive to rebuild its product pipeline via deal-making.

Contact Health Care

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More